117 related articles for article (PubMed ID: 10942044)
1. Drugs selective for nicotinic receptor subtypes: a real possibility or a dream?
Gotti C; Carbonnelle E; Moretti M; Zwart R; Clementi F
Behav Brain Res; 2000 Aug; 113(1-2):183-92. PubMed ID: 10942044
[TBL] [Abstract][Full Text] [Related]
2. Selective effects of a 4-oxystilbene derivative on wild and mutant neuronal chick alpha7 nicotinic receptor.
Maggi L; Palma E; Eusebi F; Moretti M; Balestra B; Clementi F; Gotti C
Br J Pharmacol; 1999 Jan; 126(1):285-95. PubMed ID: 10051147
[TBL] [Abstract][Full Text] [Related]
3. 4-Oxystilbene compounds are selective ligands for neuronal nicotinic alphaBungarotoxin receptors.
Gotti C; Balestra B; Moretti M; Rovati GE; Maggi L; Rossoni G; Berti F; Villa L; Pallavicini M; Clementi F
Br J Pharmacol; 1998 Jul; 124(6):1197-206. PubMed ID: 9720791
[TBL] [Abstract][Full Text] [Related]
4. MG624, an α7-nAChR antagonist, inhibits angiogenesis via the Egr-1/FGF2 pathway.
Brown KC; Lau JK; Dom AM; Witte TR; Luo H; Crabtree CM; Shah YH; Shiflett BS; Marcelo AJ; Proper NA; Hardman WE; Egleton RD; Chen YC; Mangiarua EI; Dasgupta P
Angiogenesis; 2012 Mar; 15(1):99-114. PubMed ID: 22198237
[TBL] [Abstract][Full Text] [Related]
5. bis-Azaaromatic quaternary ammonium analogues: ligands for alpha4beta2* and alpha7* subtypes of neuronal nicotinic receptors.
Ayers JT; Dwoskin LP; Deaciuc AG; Grinevich VP; Zhu J; Crooks PA
Bioorg Med Chem Lett; 2002 Nov; 12(21):3067-71. PubMed ID: 12372503
[TBL] [Abstract][Full Text] [Related]
6. Evidence of a dual mechanism of action underlying the anti-proliferative and cytotoxic effects of ammonium-alkyloxy-stilbene-based α7- and α9-nicotinic ligands on glioblastoma cells.
Pucci S; Bolchi C; Bavo F; Pallavicini M; De Palma C; Renzi M; Fucile S; Benfante R; Di Lascio S; Lattuada D; Bessereau JL; D'Alessandro M; Risson V; Zoli M; Clementi F; Gotti C
Pharmacol Res; 2022 Jan; 175():105959. PubMed ID: 34756924
[TBL] [Abstract][Full Text] [Related]
7. α9- and α7-containing receptors mediate the pro-proliferative effects of nicotine in the A549 adenocarcinoma cell line.
Mucchietto V; Fasoli F; Pucci S; Moretti M; Benfante R; Maroli A; Di Lascio S; Bolchi C; Pallavicini M; Dowell C; McIntosh M; Clementi F; Gotti C
Br J Pharmacol; 2018 Jun; 175(11):1957-1972. PubMed ID: 28726253
[TBL] [Abstract][Full Text] [Related]
8. Discovery, synthesis, and structure activity of a highly selective alpha7 nicotinic acetylcholine receptor antagonist.
Whiteaker P; Christensen S; Yoshikami D; Dowell C; Watkins M; Gulyas J; Rivier J; Olivera BM; McIntosh JM
Biochemistry; 2007 Jun; 46(22):6628-38. PubMed ID: 17497892
[TBL] [Abstract][Full Text] [Related]
9. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.
Riganti L; Matteoni C; Di Angelantonio S; Nistri A; Gaimarri A; Sparatore F; Canu-Boido C; Clementi F; Gotti C
Br J Pharmacol; 2005 Dec; 146(8):1096-109. PubMed ID: 16273122
[TBL] [Abstract][Full Text] [Related]
10. New quinoline derivatives as nicotinic receptor modulators.
Manetti D; Bellucci C; Dei S; Teodori E; Varani K; Spirova E; Kudryavtsev D; Shelukhina I; Tsetlin V; Romanelli MN
Eur J Med Chem; 2016 Mar; 110():246-58. PubMed ID: 26840365
[TBL] [Abstract][Full Text] [Related]
11. Alpha7 and alpha8 nicotinic receptor subtypes immunopurified from chick retina have different immunological, pharmacological and functional properties.
Gotti C; Moretti M; Maggi R; Longhi R; Hanke W; Klinke N; Clementi F
Eur J Neurosci; 1997 Jun; 9(6):1201-11. PubMed ID: 9215704
[TBL] [Abstract][Full Text] [Related]
12. From 2-Triethylammonium Ethyl Ether of 4-Stilbenol (MG624) to Selective Small-Molecule Antagonists of Human α9α10 Nicotinic Receptor by Modifications at the Ammonium Ethyl Residue.
Bavo F; Pallavicini M; Pucci S; Appiani R; Giraudo A; Eaton B; Lucero L; Gotti C; Moretti M; Whiteaker P; Bolchi C
J Med Chem; 2022 Jul; 65(14):10079-10097. PubMed ID: 35834819
[TBL] [Abstract][Full Text] [Related]
13. Presynaptic alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate [3H]d-aspartate release from rat frontal cortex in vitro.
Rousseau SJ; Jones IW; Pullar IA; Wonnacott S
Neuropharmacology; 2005 Jul; 49(1):59-72. PubMed ID: 15992581
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of acetylcholine-evoked responses of alpha7 neuronal nicotinic acetylcholine receptors by novel tris- and tetrakis-azaaromatic quaternary ammonium antagonists.
López-Hernández GY; Thinschmidt JS; Zheng G; Zhang Z; Crooks PA; Dwoskin LP; Papke RL
Mol Pharmacol; 2009 Sep; 76(3):652-66. PubMed ID: 19556356
[TBL] [Abstract][Full Text] [Related]
15. Nicotine at concentrations found in cigarette smokers activates and desensitizes nicotinic acetylcholine receptors in CA1 interneurons of rat hippocampus.
Alkondon M; Pereira EF; Almeida LE; Randall WR; Albuquerque EX
Neuropharmacology; 2000 Oct; 39(13):2726-39. PubMed ID: 11044743
[TBL] [Abstract][Full Text] [Related]
16. Different nicotinic acetylcholine receptor subtypes mediating striatal and prefrontal cortical [3H]dopamine release.
Cao YJ; Surowy CS; Puttfarcken PS
Neuropharmacology; 2005 Jan; 48(1):72-9. PubMed ID: 15617729
[TBL] [Abstract][Full Text] [Related]
17. The motivational valence of nicotine in the rat ventral tegmental area is switched from rewarding to aversive following blockade of the alpha7-subunit-containing nicotinic acetylcholine receptor.
Laviolette SR; van der Kooy D
Psychopharmacology (Berl); 2003 Mar; 166(3):306-13. PubMed ID: 12569428
[TBL] [Abstract][Full Text] [Related]
18. Modeling subtype-selective agonists binding with alpha4beta2 and alpha7 nicotinic acetylcholine receptors: effects of local binding and long-range electrostatic interactions.
Huang X; Zheng F; Chen X; Crooks PA; Dwoskin LP; Zhan CG
J Med Chem; 2006 Dec; 49(26):7661-74. PubMed ID: 17181149
[TBL] [Abstract][Full Text] [Related]
19. Antagonism of nicotinic receptors of rat chromaffin cells by N,N, N-trimethyl-1-(4-trans-stilbenoxy)-2-propylammonium iodide: a patch clamp and ligand binding study.
Di Angelantonio S; Nistri A; Moretti M; Clementi F; Gotti C
Br J Pharmacol; 2000 Apr; 129(8):1771-9. PubMed ID: 10780985
[TBL] [Abstract][Full Text] [Related]
20. Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists.
Jonnala RR; Buccafusco JJ
J Neurosci Res; 2001 Nov; 66(4):565-72. PubMed ID: 11746376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
